TY - JOUR
T1 - Survival from common and rare cancers in Germany in the early 21st century
AU - Hiripi, Eva
AU - Gondos, Adam
AU - Emrich, Katharina
AU - Holleczek, B.
AU - Katalinic, A.
AU - Luttmann, Sabine
AU - Sirri, Eunice
AU - Brenner, Hermann
AU - Geiss, Karla
AU - Meyer, Martin
AU - Eberle, Andrea
AU - Luttmann, Sabine
AU - Stabenow, Roland
AU - Hentschel, Stefan
AU - Nennecke, Alice
AU - Kieschke, Joachim
AU - Sirri, Eunice
AU - Holleczek, Bernd
AU - Emrich, Katharina
AU - Kajüter, Hiltraud
AU - Mattauch, Volkmar
AU - Katalinic, A.
AU - Kraywinkel, Klaus
AU - Brenner, Hermann
AU - Gondos, Adam
AU - Hiripi, Eva
PY - 2012/2/1
Y1 - 2012/2/1
N2 - Background: Until recently, population-based data of cancer survival in Germany mostly relied on one registry covering ~1 million people (1.3% of the German population). Here, we provide up-to-date cancer survival estimates for Germany based on data from 11 population-based cancer registries, covering 33 million people and compare them to survival estimates from the United States. Patients and methods: Cancer patients diagnosed in 1997-2006 were included. Period analysis was employed to calculate 5-year relative survival for 38 cancers for 2002-2006. German and USA survival rates were compared utilizing the Surveillance, Epidemiology and End Results 13 database. Results: Five-year relative survival >80% was observed for testicular cancer (93.5%), skin melanoma (89.4%), cancers of the prostate (89.1%) and thyroid (87.8%), Hodgkin's lymphoma (84.5%) and cancers of the breast (83.7%) and endometrium (81.0%), which together account for almost 40% of cases. For the majority of cancers, German survival estimates were close to or below those in the United States. Exceptions with higher survival in Germany were cancers of the stomach, pancreas and kidney and Hodgkin's lymphoma. Conclusions: German cancer survival estimates are mostly higher than the 2000-2002 pan-European estimates. Further research is needed to investigate causes responsible for differences between German and USA cancer survival rates.
AB - Background: Until recently, population-based data of cancer survival in Germany mostly relied on one registry covering ~1 million people (1.3% of the German population). Here, we provide up-to-date cancer survival estimates for Germany based on data from 11 population-based cancer registries, covering 33 million people and compare them to survival estimates from the United States. Patients and methods: Cancer patients diagnosed in 1997-2006 were included. Period analysis was employed to calculate 5-year relative survival for 38 cancers for 2002-2006. German and USA survival rates were compared utilizing the Surveillance, Epidemiology and End Results 13 database. Results: Five-year relative survival >80% was observed for testicular cancer (93.5%), skin melanoma (89.4%), cancers of the prostate (89.1%) and thyroid (87.8%), Hodgkin's lymphoma (84.5%) and cancers of the breast (83.7%) and endometrium (81.0%), which together account for almost 40% of cases. For the majority of cancers, German survival estimates were close to or below those in the United States. Exceptions with higher survival in Germany were cancers of the stomach, pancreas and kidney and Hodgkin's lymphoma. Conclusions: German cancer survival estimates are mostly higher than the 2000-2002 pan-European estimates. Further research is needed to investigate causes responsible for differences between German and USA cancer survival rates.
UR - http://www.scopus.com/inward/record.url?scp=84856321238&partnerID=8YFLogxK
U2 - 10.1093/annonc/mdr131
DO - 10.1093/annonc/mdr131
M3 - Journal articles
C2 - 21597096
AN - SCOPUS:84856321238
SN - 0923-7534
VL - 23
SP - 472
EP - 479
JO - Annals of Oncology
JF - Annals of Oncology
IS - 2
ER -